Doug Fulling

Advancing market-access marketing through experiential strategy, effective value demonstration, and market-access-focused resource development. The value of innovative medical treatments often begins with an evaluation of cost. As former payers ourselves, we know. So we identify and assess evidence of economic, clinical, and humanistic value, then analyze it to effectively demonstrate the total value of medical innovations—and maximize commercial success.